Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine and Mepivacaine vs Bupivacaine in Hip and Knee Arthroplasty
NCT04257682Phase 4Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Sep 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of ropivacaine, mepivacaine in knee osteoarthritis (OA), hip osteoarthritis, sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
ropivacainemepivacaine
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on NCT04257682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04257682.